Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.

Sakuraba A, Keyashian K, Correia C, Melek J, Cohen RD, Hanauer SB, Rubin DT. Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center. Inflamm Bowel Dis. 2013 Mar; 19(3):621-6.

View in: PubMed